|
|
Lieferanten für
Nemorubicin
|
Daten | CAS |
108852-90-0 | Formula |
C32H37NO13 |
|
|
7 Registerierte Lieferanten
Molecular Formula: C32H37NO13 Molecular Weight: 643.638
Description: Nemorubicin, is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile. The drug is active on tumors resistant to alkylating agents, topoisomerase II inhibitors and platinum derivatives. - Molecular Weight:643.23
- Boiling Point:852.2±65.0°C (Predicted)
- Purity:≥97% by HPLC
Molecular Formula: C32H37NO13 Canonical SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N6CCOC(C6)OC)O InChI: InChI=1S/C32H37NO13/c1-14-27(36)17(33-7-8-44-22(12-33)43-3)9-21(45-14)46-19-11-32(41,20(35)13-34)10-16-24(19)31(40)26-25(29(16)38)28(37)15-5-4-6-18(42-2)23(15)30(26)39/h4-6,14,17,19,21-22,27,34,36,38,40-41H,7-13H2,1-3H3/t14-,17-,19-,21-,22-,27+,32-/m0/s1 InChIKey: CTMCWCONSULRHO-UHQPFXKFSA-N Solubility: Soluble in DMSO; Insoluble in Water Appearance: Red to Pink Solid Powder Application: ADCs Cytotoxin Storage: Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years) Synonyms: Methoxymorpholinyldoxorubicin; PNU152243A; PNU-152243A; PNU 152243A; (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2S)-2-methoxymorpholin-4-yl]-α-L-lyxo-hexopyranoside; 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(2S)-2-methoxy-4-morpholinyl]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-; 3'-Deamino-3'-(2(S)-methoxy-4-morpholinyl)doxorubicin; Methoxymorpholino-doxorubicin Weitere Informationen finden Sie hier
|
|
|
Privilegierte Lieferanten
Letztes Update 2024-05-03
|